2015 Press Releases

Webcast ImageWebcast
Q4 2014 MannKind Earnings Conference Call (Replay)
02/24/15 at 2:00 p.m. PT
Webcast ImageWebcast
MannKind at RBC Capital Markets Global Healthcare Conference (Replay)
02/25/15 at 9:00 a.m. ET
Receive E-mail AlertsEmail Alerts
Sign up to receive e-mail alerts whenever MannKind has a news release. Just enter your e-mail address and click submit.
2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
02/24/15MannKind Corporation Reports 2014 Fourth Quarter and Full Year Financial Results
- Conference Call to Begin Today at 5:00 PM ET - VALENCIA, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2014. For the fourth quarter, our operating expenses declined 35% compared to the similar quarter in 2013. Research and development costs were significantly lower, mainly due to a reduction in non-cash compensation expenses and much lower clinical trial expenses followi... 
Printer Friendly Version
02/18/15MannKind Corporation to Present at the RBC Capital Markets Global Healthcare Conference
VALENCIA, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at the 2015 RBC Capital Markets Global Healthcare Conference on Wednesday, February 25, 2015 at 9:00 AM (ET) at the New York Palace in New York City.    Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company'... 
Printer Friendly Version
02/17/15MannKind Corporation to Hold 2014 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2015
VALENCIA, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 fourth quarter and full year financial results on Tuesday, February 24, 2015 and its management will host a conference call to discuss the fourth quarter and full year financial results and other Company developments at 5:00 PM (Eastern Time) on February 24, 2015. Presenting from the Company will be its Chief Executive Officer, Hakan Edstrom and Chief Financial Officer, Matthew Pfeffe... 
Printer Friendly Version
02/03/15Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.
PARIS and VALENCIA, Calif., Feb. 3, 2015 /PRNewswire/ -- Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now available by prescription in U.S. retail pharmacies nationwide. Afrezza is approved by the U.S. Food and Drug Administration to control high blood sugar in adults with type 1 and type 2 diabetes. Experience the interactive Multimedia News Release here: http://www.multivu.com/players/English/7412351-sanofi-ma... 
Printer Friendly Version
01/12/15MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
Alfred Mann to Remain Focused on Development and Financing of Future Products of MannKind VALENCIA, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a biopharmaceutical-based technology company, today announced that Alfred Mann, the company's founder, retired from his role as Chief Executive Officer effective January 9, 2015 and will transition to Executive Chairman. Mr. Mann intends to remain engaged with the company in business matters, including those relating to... 
Printer Friendly Version
01/08/15MannKind Earns $50 Million in Milestone Payments From Sanofi
VALENCIA, Calif., Jan. 8, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it has earned a total of $50 million in milestone payments in connection with the satisfaction of manufacturing milestones specified in its collaboration and licensing agreement with Sanofi. Pursuant to the agreement, MannKind previously received a $150 million upfront payment and is eligible to earn up to $725 million in further development, regulatory and sales milestones, and is also eli... 
Printer Friendly Version
01/07/15MannKind Corporation to Present at the J.P. Morgan 2015 Healthcare Conference
VALENCIA, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at the 33RD Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 1:30 PM (PST) at Westin St. Francis Hotel in San Francisco, California. Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Com... 
Printer Friendly Version


Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet